Investment, Funding & Disinvestments

The investment will fund the construction of a new 500,000-square-foot manufacturing facility, along with extensive upgrades to the company’s existing 700,000-square-foot plant in Austin, Texas.

Arprim Consultants presented a master plan and feasibility study led by Principal Architect Jared Momanyi, which sets out a phased approach to meet rising regional healthcare needs.

The ministry and Samsung is exploring plans to establish a state-of-the-art training facility equipped with advanced technologies that can support the practical training of healthcare professionals.

Evonik will use the funding to upgrade major production assets, including large reactors and other critical processing systems.

The Nottingham site also supports Codis’ commercial spray-drying operations in Haverhill, U.K., where the company is increasing capacity by installing a new GEA Pharma-SD PSD-4 commercial spray dryer, with validation planned for 2027.

Under the agreement, Everest Medicines will receive US$112.5 million upfront from Travere Therapeutics and could earn up to US$1.03 billion more in milestone payments if certain clinical, regulatory, and commercial goals are met across five indications.

The investment forms part of the hospital’s broader strategy to expand access to next-generation medical technologies despite Lebanon’s ongoing healthcare and economic challenges.

The new collaboration centres on CSPC’s small interfering RNA (siRNA) drug discovery platform and its proprietary delivery technology, which is designed to transport therapies beyond the liver.

Following the sale, Clarivate will concentrate on its Academia & Government (A&G) and Intellectual Property (IP) divisions.

The opening follows the recent launch of the hospital’s first-of-its-kind emergency CT system in Saudi Arabia, which is designed to speed up diagnosis and treatment for stroke and trauma patients.